Photo from wikipedia
https://e-kcj.org Current guidelines recommend that continuing dual antiplatelet therapy (DAPT) beyond 12 months may be reasonable in some patients with acute coronary syndrome (ACS). These include patients with non-ST elevation… Click to show full abstract
https://e-kcj.org Current guidelines recommend that continuing dual antiplatelet therapy (DAPT) beyond 12 months may be reasonable in some patients with acute coronary syndrome (ACS). These include patients with non-ST elevation (NSTE)-ACS or ST-elevation myocardial infarction (STEMI) treated with coronary stent implantation who have tolerated DAPT without a bleeding complication and do not present a high bleeding risk.1)2)
Keywords:
patients acute;
myocardial infarction;
beyond months;
dual antiplatelet;
antiplatelet therapy
Journal Title: Korean Circulation Journal
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Korean Circulation Journal
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!